Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

November 01, 2002; Volume 303,Issue 2

PERSPECTIVES IN PHARMACOLOGY

  • You have access
    ATP as a Cotransmitter in Sympathetic Nerves and Its Inactivation by Releasable Enzymes
    David P. Westfall, Latchezar D. Todorov and Svetlana T. Mihaylova-Todorova
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 439-444; DOI: https://doi.org/10.1124/jpet.102.035113

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

  • You have access
    Interactions of Human Organic Anion Transporters and Human Organic Cation Transporters with Nonsteroidal Anti-Inflammatory Drugs
    Suparat Khamdang, Michio Takeda, Rie Noshiro, Shinichi Narikawa, Atsushi Enomoto, Naohiko Anzai, Pawinee Piyachaturawat and Hitoshi Endou
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 534-539; DOI: https://doi.org/10.1124/jpet.102.037580
  • You have access
    Pharmacokinetic and Pharmacodynamic Studies of a Human Serum Albumin-Interferon-α Fusion Protein in Cynomolgus Monkeys
    Blaire L. Osborn, Henrik S. Olsen, Bernardetta Nardelli, James H. Murray, Joe X. H. Zhou, Andrew Garcia, Gordon Moody, Liubov S. Zaritskaya and Cynthia Sung
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 540-548; DOI: https://doi.org/10.1124/jpet.102.037002
  • You have access
    Secretory Transport of Ranitidine and Famotidine across Caco-2 Cell Monolayers
    Kiho Lee, Chee Ng, Kim L. R. Brouwer and Dhiren R. Thakker
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 574-580; DOI: https://doi.org/10.1124/jpet.102.038521
  • You have access
    The Importance of Tumor Glucuronidase in the Activation of Irinotecan in a Mouse Xenograft Model
    Helen M. Dodds, Peter J. Tobin, Clinton F. Stewart, Pam Cheshire, Suzan Hanna, Peter Houghton and Laurent P. Rivory
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 649-655; DOI: https://doi.org/10.1124/jpet.102.039040
  • You have access
    Pharmacokinetics and Metabolism of Infused versus Inhaled Iloprost in Isolated Rabbit Lungs
    Ralph Theo Schermuly, Andreas Schulz, Hossein Ardeschir Ghofrani, Arne Meidow, Frank Rose, Axel Roehl, Norbert Weissmann, Michael Hildebrand, Julia Kurz, Friedrich Grimminger, Dieter Walmrath and Werner Seeger
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 741-745; DOI: https://doi.org/10.1124/jpet.303.2.741
  • You have access
    Pluronic P85 Block Copolymer Enhances Opioid Peptide Analgesia
    Ken A. Witt, Jason D. Huber, Richard D. Egleton and Thomas P. Davis
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 760-767; DOI: https://doi.org/10.1124/jpet.102.039545
  • You have access
    In Vitro Stability and In Vivo Pharmacokinetic Studies of a Model Opioid Peptide, H-Tyr-d-Ala-Gly-Phe-d-Leu-OH (DADLE), and Its Cyclic Prodrugs
    Jerry Z. Yang, Weiqing Chen and Ronald T. Borchardt
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 840-848; DOI: https://doi.org/10.1124/jpet.102.037135
  • You have access
    Evaluation of the Permeation Characteristics of a Model Opioid Peptide, H-Tyr-d-Ala-Gly-Phe-d-Leu-OH (DADLE), and Its Cyclic Prodrugs across the Blood-Brain Barrier Using an In Situ Perfused Rat Brain Model
    Weiqing Chen, Jerry Z. Yang, Rikke Andersen, Lisbeth H. Nielsen and Ronald T. Borchardt
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 849-857; DOI: https://doi.org/10.1124/jpet.102.037143
  • You have access
    Renal Disposition of a Furan Dicarboxylic Acid and Other Uremic Toxins in the Rat
    Yasuhiro Tsutsumi, Tsuneo Deguchi, Mikihisa Takano, Akira Takadate, W. Edward Lindup and Masaki Otagiri
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 880-887; DOI: https://doi.org/10.1124/jpet.303.2.880

BEHAVIORAL PHARMACOLOGY

  • You have access
    Synergy between μ Opioid Ligands: Evidence for Functional Interactions among μ Opioid Receptor Subtypes
    Elizabeth A. Bolan, Ronald J. Tallarida and Gavril W. Pasternak
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 557-562; DOI: https://doi.org/10.1124/jpet.102.035881
  • You have access
    The Reinforcing Efficacy of the Dopamine Reuptake Inhibitor 2β-Propanoyl-3β-(4-tolyl)-tropane (PTT) as Measured by a Progressive-Ratio Schedule and a Choice Procedure in Rhesus Monkeys
    Joshua A. Lile, Drake Morgan, Anne M. Birmingham, Zhixia Wang, William L. Woolverton, Huw M. L. Davies and Michael A. Nader
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 640-648; DOI: https://doi.org/10.1124/jpet.102.039180
  • You have access
    Self-Administration of Intravenous Buprenorphine and the Buprenorphine/Naloxone Combination by Recently Detoxified Heroin Abusers
    Sandra D. Comer and Eric D. Collins
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 695-703; DOI: https://doi.org/10.1124/jpet.102.038141
  • You have access
    5-Ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N- (2-fluorophenyl)carboxamide (RWJ-51204), a New Nonbenzodiazepine Anxiolytic
    Barry Dubinsky, Anil H. Vaidya, Daniel I. Rosenthal, Coralie Hochman, Jeffrey J. Crooke, Samantha DeLuca, Ann DeVine, Cathy T. Cheo-Isaacs, Alexandre R. Carter, Alfonzo D. Jordan, Allen B. Reitz and Richard P. Shank
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 777-790; DOI: https://doi.org/10.1124/jpet.102.036954

CARDIOVASCULAR

  • You have access
    Angiotensin II Increases Expression of Cyclooxygenase-2: Implications for the Function of Vascular Smooth Muscle Cells
    Zhuo-Wei Hu, Reinhold Kerb, Xiao-You Shi, Tzuping Wei-Lavery and Brian B. Hoffman
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 563-573; DOI: https://doi.org/10.1124/jpet.102.037705
  • You have access
    Induction of Hypertrophic Responsiveness of Cardiomyocytes to Neuropeptide Y in Response to Pressure Overload
    David Bell, Adrian R. Allen, Elizabeth J. Kelso, Ambikaipakan Balasubramaniam and Barbara J. McDermott
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 581-591; DOI: https://doi.org/10.1124/jpet.102.038448
  • You have access
    Pharmacological Profile of the Novel Inotropic Agent (E,Z)-3-((2-Aminoethoxy)imino)androstane-6,17-dione Hydrochloride (PST2744)
    R. Micheletti, G. G. Mattera, M. Rocchetti, A. Schiavone, M. F. Loi, A. Zaza, R. J. P. Gagnol, S. De Munari, P. Melloni, P. Carminati, G. Bianchi and P. Ferrari
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 592-600; DOI: https://doi.org/10.1124/jpet.102.038331
  • You have access
    Combined Inotropic and Bradycardic Effects of a Sodium Channel Enhancer in Conscious Dogs with Heart Failure: A Mechanism for Improved Myocardial Efficiency Compared with Dobutamine
    Weiqun Shen, Robert M. Gill, Bonita D. Jones, Jian-Ping Zhang, Angela K. Corbly and Mitchell I. Steinberg
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 673-680; DOI: https://doi.org/10.1124/jpet.303.2.673
  • You have access
    Carrier-Mediated Norepinephrine Release and Reperfusion Arrhythmias Induced by Protracted Ischemia in Isolated Perfused Guinea Pig Hearts: Effect of Presynaptic Modulation by α2-Adrenoceptor in Mild Hypothermic Ischemia
    Jun-ichi Oka, Michiaki Imamura, Eiichiro Hatta, Ryushi Maruyama, Mitsuhiro Isaka, Toshifumi Murashita and Keishu Yasuda
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 681-687; DOI: https://doi.org/10.1124/jpet.102.036863
  • You have access
    Influence of Opioid Agonists on Cardiac HumanEther-a-go-go-related Gene K+ Currents
    Alexander N. Katchman, Kelly A. McGroary, Michael J. Kilborn, Craig A. Kornick, Paolo L. Manfredi, Raymond L. Woosley and Steven N. Ebert
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 688-694; DOI: https://doi.org/10.1124/jpet.102.038240
  • You have access
    Cytochrome P-450 Epoxygenase Metabolites of Docosahexaenoate Potently Dilate Coronary Arterioles by Activating Large-Conductance Calcium-Activated Potassium Channels
    Dan Ye, David Zhang, Christine Oltman, Kevin Dellsperger, Hon-Chi Lee and Mike VanRollins
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 768-776; DOI: https://doi.org/10.1124/jpet.303.2.768
  • You have access
    Involvement of NO in the Endothelium-Independent Relaxing Effects of N ω-Hydroxy-l-arginine and Other Compounds Bearing a C=NOH Function in the Rat Aorta
    Petr Vetrovsky, Jean-Luc Boucher, Christa Schott, Petra Beranova, Karel Chalupsky, Noëlle Callizot, Bernard Muller, Gustav Entlicher, Daniel Mansuy and Jean-Claude Stoclet
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 823-830; DOI: https://doi.org/10.1124/jpet.102.038612

CELLULAR AND MOLECULAR

  • You have access
    Transporter Gene Expression in Lactating and Nonlactating Human Mammary Epithelial Cells Using Real-Time Reverse Transcription-Polymerase Chain Reaction
    J. Alcorn, X. Lu, J. A. Moscow and P. J. McNamara
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 487-496; DOI: https://doi.org/10.1124/jpet.102.038315
  • You have access
    Perturbation by Geraniol of Cell Membrane Permeability and Signal Transduction Pathways in Human Colon Cancer Cells
    S. Carnesecchi, A. Bradaia, B. Fischer, D. Coelho, M. Schöller-Guinard, F. Gosse and F. Raul
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 711-715; DOI: https://doi.org/10.1124/jpet.102.039263
  • You have access
    Activation of Extracellular-Regulated Kinase by 5-Hydroxytryptamine2A Receptors in PC12 Cells is Protein Kinase C-Independent and Requires Calmodulin and Tyrosine Kinases
    John C. Quinn, Nadine N. Johnson-Farley, JiYoung Yoon and Daniel S. Cowen
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 746-752; DOI: https://doi.org/10.1124/jpet.102.038083

CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY

  • You have access
    A Targeted Inhibition of DNA-Dependent Protein Kinase Sensitizes Breast Cancer Cells Following Ionizing Radiation
    Chung-Hui Kim, Su-Jung Park and Suk-Hee Lee
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 753-759; DOI: https://doi.org/10.1124/jpet.102.038505

ENDOCRINE AND REPRODUCTIVE

  • You have access
    Identification of a Peptide Antagonist to the Peripheral-Type Benzodiazepine Receptor That Inhibits Hormone-Stimulated Leydig Cell Steroid Formation
    Maria Gazouli, Zeqiu Han and Vassilios Papadopoulos
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 627-632; DOI: https://doi.org/10.1124/jpet.102.039388

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

  • You have access
    Elucidation of the Vasoactive Intestinal Peptide Pharmacophore for VPAC2 Receptors in Human and Rat and Comparison to the Pharmacophore for VPAC1 Receptors
    Hisato Igarashi, Tetsuhide Ito, Tapas K. Pradhan, Samuel A. Mantey, Wei Hou, David H. Coy and Robert T. Jensen
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 445-460; DOI: https://doi.org/10.1124/jpet.102.038075
  • You have access
    Cholestasis Increases Tumor Necrosis Factor-Related Apoptotis-Inducing Ligand (TRAIL)-R2/DR5 Expression and Sensitizes the Liver to TRAIL-Mediated Cytotoxicity
    Hajime Higuchi, Steven F. Bronk, Makiko Taniai, Ali Canbay and Gregory J. Gores
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 461-467; DOI: https://doi.org/10.1124/jpet.102.040030
  • You have access
    Ulcerogenic Influence of Selective Cyclooxygenase-2 Inhibitors in the Rat Stomach with Adjuvant-Induced Arthritis
    Shinichi Kato, Yoshihiro Ogawa, Kenji Kanatsu, Mitsuaki Okayama, Toshio Watanabe, Tetsuo Arakawa and Koji Takeuchi
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 503-509; DOI: https://doi.org/10.1124/jpet.102.040659
  • You have access
    Reduced Liver Uptake of Arterially Infused Melphalan during Retrograde Rat Liver Perfusion with Unaffected Liver Tumor Uptake
    Joost Rothbarth, Rolf W. Sparidans, Jos H. Beijnen, Leo J. Schultze Kool, Hein Putter, Cornelis J. H. van de Velde and Gerard J. Mulder
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 736-740; DOI: https://doi.org/10.1124/jpet.102.037895

INFLAMMATION AND IMMUNOPHARMACOLOGY

  • You have access
    Effect of Heat Stress on Lipopolysaccharide-Induced Vascular Permeability Change in Mice
    Taiyo Suganuma, Kaoru Irie, Emiko Fujii, Toshimasa Yoshioka and Takamura Muraki
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 656-663; DOI: https://doi.org/10.1124/jpet.102.035758
  • You have access
    The Identification and Characterization of the Marine Natural Product Scytonemin as a Novel Antiproliferative Pharmacophore
    Christopher S. Stevenson, Elizabeth A. Capper, Amy K. Roshak, Brian Marquez, Chris Eichman, Jeffrey R. Jackson, Michael Mattern, William H. Gerwick, Robert S. Jacobs and Lisa A. Marshall
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 858-866; DOI: https://doi.org/10.1124/jpet.102.036350

NEUROPHARMACOLOGY

  • You have access
    Effects of Dopamine Receptor Blockade on Cerebral Blood Flow Response to Somatosensory Stimulation in the Unanesthetized Rat
    Takanori Esaki, Yoshiaki Itoh, Kazuaki Shimoji, Michelle Cook, Jane Jehle and Louis Sokoloff
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 497-502; DOI: https://doi.org/10.1124/jpet.102.039081
  • You have access
    P2Y-Receptors Mediating an Inhibition of the Evoked Entry of Calcium through N-Type Calcium Channels at Neuronal Processes
    Melanie B. Kulick and Ivar von Kügelgen
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 520-526; DOI: https://doi.org/10.1124/jpet.102.037960
  • You have access
    Opioid Receptor Subtypes Differentially Modulate Serotonin Efflux in the Rat Central Nervous System
    Rui Tao and Sidney B. Auerbach
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 549-556; DOI: https://doi.org/10.1124/jpet.102.037861
  • You have access
    Modulation of Group II Metabotropic Glutamate Receptor Signaling by Chronic Cocaine
    Zheng-Xiong Xi, Sammanda Ramamoorthy, David A. Baker, Hui Shen, Devadoss J. Samuvel and Peter W. Kalivas
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 608-615; DOI: https://doi.org/10.1124/jpet.102.039735
  • You have access
    Neuroactive Steroids Differ in Potency but Not in Intrinsic Efficacy at the GABAA Receptor in Vivo
    S. A. G. Visser, W. W. F. T. Gladdines, P. H. van der Graaf, L. A. Peletier and M. Danhof
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 616-626; DOI: https://doi.org/10.1124/jpet.102.039610
  • You have access
    Declines in Different β2* Nicotinic Receptor Populations in Monkey Striatum after Nigrostriatal Damage
    Jennifer M. Kulak, John L. Musachio, J. Michael McIntosh and Maryka Quik
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 633-639; DOI: https://doi.org/10.1124/jpet.102.039347
  • You have access
    Reboxetine: Attenuation of Intravenous Nicotine Self-Administration in Rats
    Anthony S. Rauhut, Stephanie N. Mullins, Linda P. Dwoskin and Michael T. Bardo
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 664-672; DOI: https://doi.org/10.1124/jpet.303.2.664
  • You have access
    GABAergic and Glutamatergic Afferents in the Dorsal Raphe Nucleus Mediate Morphine-Induced Increases in Serotonin Efflux in the Rat Central Nervous System
    Rui Tao and Sidney B. Auerbach
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 704-710; DOI: https://doi.org/10.1124/jpet.102.038133
  • You have access
    Characterization of the Vanilloid Receptor 1 Antagonist Iodo-Resiniferatoxin on the Afferent and Efferent Function of Vagal Sensory C-Fibers
    Bradley J. Undem and Marian Kollarik
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 716-722; DOI: https://doi.org/10.1124/jpet.102.039727
  • You have access
    Comparison of Receptor Mechanisms and Efficacy Requirements for δ-Agonist-Induced Convulsive Activity and Antinociception in Mice
    Daniel C. Broom, Joshua F. Nitsche, John E. Pintar, Kenner C. Rice, James H. Woods and John R. Traynor
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 723-729; DOI: https://doi.org/10.1124/jpet.102.036525
  • You have access
    Gabapentin and the Neurokinin1 Receptor Antagonist CI-1021 Act Synergistically in Two Rat Models of Neuropathic Pain
    Mark J. Field, M. Isabel Gonzalez, Ronald J. Tallarida and Lakhbir Singh
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 730-735; DOI: https://doi.org/10.1124/jpet.102.033134
  • You have access
    Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes
    Mark J. Millan, Lisa Maiofiss, Didier Cussac, Valérie Audinot, Jean-A. Boutin and Adrian Newman-Tancredi
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 791-804; DOI: https://doi.org/10.1124/jpet.102.039867
  • You have access
    Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. II. Agonist and Antagonist Properties at Subtypes of Dopamine D2-Like Receptor and α1/α2-Adrenoceptor
    Adrian Newman-Tancredi, Didier Cussac, Valérie Audinot, Jean-Paul Nicolas, Frédéric De Ceuninck, Jean-A. Boutin and Mark J. Millan
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 805-814; DOI: https://doi.org/10.1124/jpet.102.039875
  • You have access
    Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. III. Agonist and Antagonist Properties at Serotonin, 5-HT1 and 5-HT2, Receptor Subtypes
    Adrian Newman-Tancredi, Didier Cussac, Yann Quentric, Manuelle Touzard, Laurence Verrièle, Nathalie Carpentier and Mark J. Millan
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 815-822; DOI: https://doi.org/10.1124/jpet.102.039883
  • You have access
    Effect of Glucoprivation on Serotonin Neurotoxicity Induced by Substituted Amphetamines
    Jie Yuan, Branden J. Cord, Una D. McCann, Brian T. Callahan and George A. Ricaurte
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 831-839; DOI: https://doi.org/10.1124/jpet.102.041277
  • You have access
    Spinal Pretreatment with Antisense Oligodeoxynucleotides against Exon-1, -4, or -8 of μ-Opioid Receptor Clone Leads to Differential Loss of Spinal Endomorphin-1-and Endomorphin-2-Induced Antinociception in the Mouse
    Hsiang-en Wu, Hirokazu Mizoguchi, Maia Terashvili, Randy J. Leitermann, Kuei-chun Hung, James M. Fujimoto and Leon F. Tseng
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 867-873; DOI: https://doi.org/10.1124/jpet.102.038810
  • You have access
    d-Pro2-Endomorphin-1 andd-Pro2-Endomorphin-2, Respectively, Attenuate the Antinociception Induced by Endomorphin-1 and Endomorphin-2 Given Intrathecally in the Mouse
    Kuei-chun Hung, Hsiang-en Wu, Hirokazu Mizoguchi, Shinobu Sakurada, Toru Okayama, Tsutomu Fujimura, Kimie Murayama, Tsukasa Sakurada, James M. Fujimoto and Leon F. Tseng
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 874-879; DOI: https://doi.org/10.1124/jpet.102.038927

TOXICOLOGY

  • You have access
    Peroxynitrite Is a Critical Mediator of Acetaminophen Hepatotoxicity in Murine Livers: Protection by Glutathione
    Tamara R. Knight, Ye-Shih Ho, Anwar Farhood and Hartmut Jaeschke
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 468-475; DOI: https://doi.org/10.1124/jpet.102.038968
  • You have access
    Protection of NRK-52E Cells, a Rat Renal Proximal Tubular Cell Line, from Chemical-Induced Apoptosis by Overexpression of a Mitochondrial Glutathione Transporter
    Lawrence H. Lash, David A. Putt and Larry H. Matherly
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 476-486; DOI: https://doi.org/10.1124/jpet.102.040220
  • You have access
    Cyanide Induces Different Modes of Death in Cortical and Mesencephalon Cells
    K. Prabhakaran, L. Li, J. L. Borowitz and G. E. Isom
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 510-519; DOI: https://doi.org/10.1124/jpet.102.039453
  • You have access
    2′-NH2-MPTP [1-Methyl-4-(2′-aminophenyl)-1,2,3,6-tetrahydropyridine] Depletes Serotonin and Norepinephrine in Rats: A Comparison with 2′-CH3-MPTP [1-Methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine]
    Erica L. Unger, Pascale Mazzola-Pomietto, Dennis L. Murphy and Anne M. Andrews
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 527-533; DOI: https://doi.org/10.1124/jpet.102.037614
  • You have access
    The Critical Role of Mitochondrial Energetic Impairment in the Toxicity of Nimesulide to Hepatocytes
    Fábio E. Mingatto, Tiago Rodrigues, Acácio A. Pigoso, Sérgio A. Uyemura, Carlos Curti and Antonio C. Santos
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 601-607; DOI: https://doi.org/10.1124/jpet.102.038620

Erratum

  • You have access
    Correction to “Paraherquamide and 2-Deoxy-paraherquamide Distinguish Cholinergic Receptor Subtypes in AscarisMuscle”
    Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 888;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 303 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 303, Issue 2
1 Nov 2002
  • Table of Contents
  • Index by author
Sign up for alerts

Jump to

  • PERSPECTIVES IN PHARMACOLOGY
  • ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
  • BEHAVIORAL PHARMACOLOGY
  • CARDIOVASCULAR
  • CELLULAR AND MOLECULAR
  • CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY
  • ENDOCRINE AND REPRODUCTIVE
  • GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
  • INFLAMMATION AND IMMUNOPHARMACOLOGY
  • NEUROPHARMACOLOGY
  • TOXICOLOGY
  • Erratum
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics